Current Report Filing (8-k)
September 11 2015 - 12:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): August 28, 2015
MEDIFIRST
SOLUTIONS, INC.
(Exact name of registrant as specified in its
charter)
Nevada |
|
|
|
27-3888260 |
State or other jurisdiction
incorporation |
|
Commission File Number |
|
IRS Employer
Identification No. |
4400
Route 9 South, Suite 1000, Freehold, NJ |
|
07728 |
(Address of principal executive offices) |
|
(Zip
Code) |
Registrant's telephone
number, including area code: (732)-786-8044
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 7 - Regulation FD
Item 7.01 Regulation FD Disclosure
On August 28, 2015, the Company was advised by The Center for Devices
and Radiological of the U.S. Food and Drug Administration that the Company’s 510(k) submission for the Company’s “The
Time Machine” Series Lasers was accepted and assigned a unique document control number.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
MEDIFIRST SOLUTIONS, INC. |
|
|
|
Dated: September 11, 2015 |
By: |
/s/ Bruce Schoengood |
|
|
President and Chief Executive Officer |